Vall d’Hebron Institute of Oncology (VHIO)
Academic institution

Barcelona
Spain


VHIO scientists and physicians work together to both accelerate and advance personalized and targeted therapies against cancer
VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer.

VHIO is a center of biomedical research with scientists and physicians working together at the nexus of basic science and clinical research. Our main purpose is to promote and develop research excellence relating to oncological diseases. VHIO also pursues to make contributions to the development of new and better therapies for the treatment of cancer.

- Scientific practice into the clinic for the benefit of oncology patients
- Scientific research excellence in the areas of basic, translational and clinical research
- Scientific cooperation among national and international oncology research institutions
- Promotion of all oncology research-related activities, thereby contributing towards improving the quality of life of people

Represented by:

Josep Tabernero logotype
Josep Tabernero

Director and Clinical Research Director, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Jordi Rodon logotype
Jordi Rodon

Clinical Head and Co-Director, Research Unit for Molecular Therapy of Cancer; Head, Early Clinical Drug Development Group, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Alejandro Piris logotype
Alejandro Piris

Scientific Research Manager, Vall d'Hebron Institute of Oncology, VHIO (Spain)